Glucose-based dialysis fluids inhibit innate defense against Staphylococcus aureus

Area of Science:

• Immunology
• Nephrology
• Microbiology

Background:

• Staphylococcus aureus peritonitis is a severe complication of Chronic Peritoneal Dialysis (CPD).
• High glucose concentrations in peritoneal dialysis (PD) fluids are known to inhibit complement-mediated host defenses against S. aureus.
• This suggests glucose-based PD fluids may increase the risk of S. aureus peritonitis.

Purpose of the Study:

• To investigate the impact of glucose-based PD fluids on complement-mediated host defenses against S. aureus.
• To compare the effects of different PD fluid compositions (glucose, icodextrin, amino acids) on S. aureus opsonophagocytosis.

Main Methods:

• Commercially available PD fluids (glucose-based, icodextrin-based, amino acid-based) were tested.
• Complement effectors including opsonization, anaphylatoxin generation, and phagocytosis efficiency against S. aureus were analyzed.
• Clinical strains of S. aureus, including MRSA, were evaluated.

Main Results:

• Glucose-based PD fluids significantly inhibited complement opsonization of S. aureus (≥7-fold reduction).
• These fluids also reduced S. aureus-induced generation of anaphylatoxins C3a and C5a (>10-fold reduction).
• Inhibition of opsonization correlated with decreased neutrophil phagocytosis of S. aureus.

Conclusions:

• Glucose-based PD fluids severely inhibit complement-mediated opsonophagocytosis and anaphylatoxin generation against S. aureus.
• These inhibitory effects on host defenses may elevate the risk and severity of S. aureus peritonitis in CPD patients.
• Non-glucose-based PD fluids may offer a safer alternative for patients at risk of S. aureus peritonitis.